Rheumastat

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameRheumastat
Drug Alias NameChemically Modified Tetracyclines (CollaGenex)matrix metalloproteinase inhibitors (CollaGenex)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionCollagenase inhibitorsGelatinases inhibitors
TargetsCollagenaseGelatinases
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState University of New York at Stony Brook
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe State University of New YorkCollagenex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A